+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Transdermal Patches Market by Type (Drug-in-adhesives, Matrix, Reservoir Membrane), Adhesive (Acrylic, Silicone, Hydrogel), Application (Pain, CVS, Hormonal), Distribution Channel (Pharmacy (Retail Online, Hospital)), End-user, and Region - Forecast to 2029

  • PDF Icon

    Report

  • 282 Pages
  • November 2023
  • Region: Global
  • Markets and Markets
  • ID: 5912523

The global transdermal patches market is projected to reach USD 8 Billion by 2029 from USD 6.2 Billion in 2023, at a CAGR of 4.5% from 2023 to 2029. The factors driving the growth of the global transdermal patches market include the rising prevalence of chronic diseases, the expanding use of analgesic patches, technological advancements in transdermal patches, and the shift from traditional injections to transdermal patches. Nonetheless, during the anticipated period, factors such as drug failures, recalls of transdermal drug delivery systems, and increasing healthcare facility expenses will probably constrain market expansion to some degree.

The matrix patches segment is expected to grow with the highest CAGR in patch type of the transdermal patches market

Due to a number of characteristics that increase the patch's appeal and efficacy, the matrix patches segment is expected to grow at the highest CAGR in the transdermal patch market. In matrix patches, the medicine is evenly dispersed within a polymer matrix, providing a straightforward but effective design. This design promotes the best possible drug absorption via the skin by enabling a prolonged, regulated release of the medicinal substance. Due to its adaptability, matrix patches are widely used in a variety of therapeutic fields. This is because they may be used to administer a broad range of drugs. Patient compliance and matrix patch efficacy are increasing as a result of ongoing technological improvements in matrix patch formulation and manufacturing.

The silicone adhesives segment is expected to grow with the highest CAGR in the adhesive type of the transdermal patches market

Since silicone adhesives have particular advantages over other adhesives, it is expected that the silicone adhesive patches segment of the transdermal patch market will grow at the fastest CAGR. Silicone adhesives ensure patient comfort and adherence by forming a thin yet strong connection with the skin. Because they are biocompatible and hypoallergenic, they can be used by a wide range of patients with less chance of skin sensitivity or irritation. Silicone adhesive patches' conformability and flexibility make them more comfortable to wear and encourage prolonged and regular use.

Based on the Application Type, the pain management segment is expected to grow by the highest CAGR in the transdermal patches market

The market for transdermal patches is expected to grow at the fastest rate in the pain management segment due to the growing need for safe, non-invasive pain reduction options. Pain-relieving transdermal patches deliver an even and steady therapeutic impact by releasing analgesic drugs through the skin in a targeted and regulated manner. This method offers an alternative to invasive therapies and conventional oral drugs, making it especially tempting to people with chronic pain disorders.

Based on the Distribution Channel, The online Pharmacies segment is expected to grow with the highest CAGR in the transdermal patches market

As a distribution channel for transdermal patches, the online pharmacies segment is anticipated to grow at the fastest rate in the market. This is due to the general trend of digitalization and the growing dependence of healthcare items on e-commerce platforms. Customers can get transdermal patches easily and conveniently from the comfort of their homes with the help of online pharmacies. The increasing popularity of e-commerce, together with its convenient ordering and doorstep delivery features, corresponds with the changing needs of patients who want hassle-free access to healthcare.

Based on the End User, The Homecare Settings segment is expected to grow with the highest CAGR in the transdermal patches market

Given the growing trend towards patient-centered and personalized healthcare, the transdermal patch market's homecare settings sector is expected to grow at the fastest rate as an end-user. For self-administration in domestic settings, transdermal patches are especially well-suited since they offer a convenient and non-invasive way to administer medication. The need for accessible, long-term treatment alternatives is fueled by the aging population and the rise of chronic illnesses. Transdermal patches are a perfect fit with this new paradigm in healthcare since homecare settings provide people the freedom to take care of their healthcare needs on their own.

Asia-Pacific to grow with the highest CAGR in the transdermal patches market during the forecast period

The transdermal patch market in Asia-Pacific is expected to grow at the highest CAGR due to an array of factors that highlight the region's changing healthcare landscape. Transdermal patches are becoming more and more popular due to the rising incidence of chronic illnesses and rising knowledge of non-invasive medication delivery techniques. The huge and aging population in the area is a major factor in the rising cost of healthcare, which in turn is driving up demand for accessible and patient-friendly treatment choices. The transdermal patch market in Asia-Pacific is also expected to rise as a result of breakthroughs in pharmaceutical research and development, rising disposable incomes, and improved healthcare infrastructure.

A breakdown of the primary participants (supply-side) for the transdermal patches market referred to for this report is provided below:

  • By Company Type: Tier 1 - 45%, Tier 2 - 30%, and Tier 3 - 25%
  • By Designation: C-level - 42%, Director Level - 29%, and Others - 29%
  • By Region: North America - 30%, Europe - 25%, Asia-Pacific - 30%, Latin America - 10%, and Middle East & Africa - 5%

The prominent players in the transdermal patches market include Johnson & Johnson (U.S.), Viatris Inc. (U.S.), Hisamatsu Pharmaceuticals Co. Ltd. (Japan), Cipla Inc. (India), Teva Pharmaceutical Industries Ltd. (Israel), Agile Therapeutics (U.S.), Bayer AG (Germany), Luye Pharma Group (China), Sparsha Pharma International Pvt Ltd (India), Iontopatch (U.S.), Medherant Limited (U.K.), AdhexPharma (France), Evernow (U.S.), Amneal Pharmaceuticals LLC. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Alvogen Group Inc. (U.S.), Novartis AG (Switzerland), AbbVie Inc. (U.S.), Nitto Denko Corporation (Japan), USB S.A. (Belgium), Boehringer Ingelheim International GmbH (Germany), Endo International plc. (Ireland), LEAD CHEMICAL Co., Ltd. (Japan), Purdue Pharma L.P (U.S.) and Mundipharma International (U.K.).

Research Coverage

The market study covers the transdermal patches market across various segments. It aims to estimate the market size and the growth potential of this market across different segments by patch type, adhesive type, application, distribution type, end-user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall transdermal patches market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

  • Analysis of key drivers (Increasing prevalence of chronic diseases, Growing adoption of analgesic patches, Technological advancements in transdermal patches, Switching from conventional needle injections to transdermal patches), restraints (High procedural cost of vascular surgeries and associated products, Drug failure and recalls of transdermal drug delivery systems, Rising cost of healthcare facilities), opportunities (Collaborations between pharmaceutical companies and drug delivery firms, Self-administration and home care drug delivery systems) and challenges (Technical barriers related to skin irritation and permeability, Lack of skilled professionals).
  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global transdermal patches market. The report analyzes this market by patch type, adhesive type, application, distribution channel, end-user, and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global transdermal patches market.
  • Market Development: Comprehensive information on the lucrative emerging markets by patch type, adhesive type, application, distribution channel, end-user, and region.
  • Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global transdermal patches market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global transdermal patches market.

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Inclusions and Exclusions of Study
1.3.2 Markets Covered
1.3.3 Years Considered
1.4 Currency
Table 1 Standard Currency Conversion Rates
1.5 Stakeholders
1.6 Recession Impact
2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
Figure 2 Primary Sources
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
Figure 3 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants
Figure 4 Breakdown of Primary Interviews (Supply Side): by Company Type, Designation, and Region
Figure 5 Breakdown of Primary Interviews (Demand Side): by End-user, Designation, and Region
2.2 Market Size Estimation
Figure 6 Supply-Side Market Size Estimation: Revenue Share Analysis
Figure 7 Revenue Share Analysis Illustration: Johnson & Johnson
Figure 8 Supply-Side Market Size Estimation: Transdermal Patches Market (2022)
Figure 9 Bottom-Up Approach
Figure 10 Top-Down Approach
Figure 11 CAGR Projections from Drivers, Restraints, Opportunities, and Challenges (2023-2029)
Figure 12 CAGR Projections: Supply-Side Analysis
2.3 Market Breakdown and Data Triangulation
Figure 13 Data Triangulation Methodology
2.4 Market Share Estimation
2.5 Assumptions for Study
2.6 Research Limitations
2.6.1 Scope-Related Limitations
2.6.2 Methodology-Related Limitations
2.7 Risk Assessment
Table 2 Risk Assessment: Transdermal Patches Market
2.8 Impact of Recession on Transdermal Patches Market
3 Executive Summary
Figure 14 Transdermal Patches Market, by Patch Type, 2023 vs. 2029 (USD Million)
Figure 15 Transdermal Patches Market, by Adhesive Type, 2023 vs. 2029 (USD Million)
Figure 16 Transdermal Patches Market, by Application, 2023 vs. 2029 (USD Million)
Figure 17 Transdermal Patches Market, by Distribution Channel, 2023 vs. 2029 (USD Million)
Figure 18 Transdermal Patches Market, by End-user, 2023 vs. 2029 (USD Million)
Figure 19 Geographical Snapshot of Transdermal Patches Market
4 Premium Insights
4.1 Transdermal Patches Market Overview
Figure 20 Rising Prevalence of Chronic Diseases to Drive Market
4.2 Asia-Pacific: Transdermal Patches Market, by Patch Type and Country (2022)
Figure 21 Drug-In-Adhesive Patches Segment Accounted for Largest Market Share in 2022
4.3 Transdermal Patches Market: Geographic Growth Opportunities
Figure 22 China to Register Highest Growth During Forecast Period
4.4 Transdermal Patches Market, Regional Mix, 2021-2029
Figure 23 North America Will Continue to Dominate Transdermal Patches Market During Forecast Period
4.5 Transdermal Patches Market: Developing vs. Developed Markets
Figure 24 Developing Markets to Register Higher Growth During Forecast Period
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 25 Transdermal Patches Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Chronic Diseases
5.2.1.2 Growing Adoption of Analgesic Patches
5.2.1.3 Technological Advancements in Transdermal Patches
5.2.1.4 Switching from Conventional Needle Injections to Transdermal Patches
5.2.2 Restraints
5.2.2.1 High Procedural Cost of Transdermal Surgeries and Associated Products
5.2.2.2 Drug Failure and Recalls of Transdermal Drug Delivery Systems
5.2.2.3 Rising Cost of Healthcare Facilities
5.2.3 Opportunities
5.2.3.1 Collaborations Between Pharmaceutical Companies and Drug Delivery Firms
5.2.3.2 Self-Administration and Home Care Drug Delivery Systems
5.2.4 Challenges
5.2.4.1 Technical Barriers Related to Skin Irritation and Permeability
5.2.4.2 Lack of Skilled Professionals
5.3 Technology Analysis
5.4 Industry Trends
5.4.1 Advancements in Transdermal Drug Delivery Systems
5.5 Value Chain Analysis
Figure 26 Transdermal Patches Market: Value Chain Analysis
5.6 Supply Chain Analysis
Figure 27 Transdermal Patches Market: Supply Chain Analysis
5.7 Trade Analysis
5.7.1 Trade Analysis for Transdermal Patches
Table 3 Import and Export Data for Transdermal Patches, by Country, 2022
5.8 Porter's Five Forces Analysis
Table 4 Transdermal Patches Market: Porter's Five Forces Analysis
5.8.1 Threat of New Entrants
5.8.2 Threat of Substitutes
5.8.3 Bargaining Power of Buyers
5.8.4 Bargaining Power of Suppliers
5.8.5 Intensity of Competitive Rivalry
5.9 Tariff and Regulatory Landscape
5.9.1 Regulatory Analysis
5.9.1.1 North America
5.9.1.1.1 US
5.9.1.1.2 Canada
5.9.1.2 Europe
5.9.1.3 Asia-Pacific
5.9.1.3.1 China
5.9.1.3.2 Japan
5.9.1.3.3 India
5.9.1.4 Latin America
5.9.1.4.1 Brazil
5.9.1.4.2 Mexico
5.9.1.5 Middle East
5.9.1.6 Africa
5.9.2 Regulatory Bodies, Government Agencies, and Other Organizations
Table 5 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 6 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 7 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 8 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 9 Rest of the World: Regulatory Bodies, Government Agencies, and Other Organizations
5.10 Patent Analysis
5.10.1 Patent Publication Trends for Transdermal Patches
Figure 28 Patent Publication Trends (January 2015-December 2022)
5.10.2 Jurisdiction Analysis: Top Applicants for Patents in Transdermal Patches Market
Figure 29 Top Applicants & Owners (Companies/Institutes) for Transdermal Patch Patents (January 2015-December 2022)
Figure 30 Top Applicant Countries/Regions for Transdermal Patches (January 2015-April 2022)
5.11 Pricing Analysis
Table 10 Average Selling Price Trends of Key Players, by Application
Table 11 Regional Pricing Analysis of Transdermal Patches, 2023 (USD)
5.12 Key Conferences & Events in 2023-2024
Table 12 Transdermal Patches Market: Detailed List of Conferences & Events
5.13 Key Stakeholders & Buying Criteria
5.13.1 Key Stakeholders in Buying Process
Figure 31 Influence of Stakeholders on Buying Process of Transdermal Patches
Table 13 Influence of Stakeholders on Buying Process of Transdermal Patches
5.13.2 Buying Criteria
Figure 32 Key Buying Criteria for Transdermal Patches
Table 14 Key Buying Criteria for Transdermal Patches
5.14 Ecosystem/Market Map
Figure 33 Transdermal Patches Market: Ecosystem/Market Map
5.15 Adjacent Market Analysis
Figure 34 Transdermal Patches Market: Adjacent Markets
5.16 Trends/Disruptions Impacting Customer's Business
Figure 35 Trends/Disruptions Impacting Customer's Business
5.17 Unmet Needs
6 Transdermal Patches Market, by Patch Type
6.1 Introduction
Table 15 Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
6.2 Drug-In-Adhesive Patches
Table 16 Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 17 Drug-In-Adhesive Transdermal Patches Market, by Country, 2021-2029 (USD Million)
6.2.1 Single-Layer Drug-In-Adhesive Patches
6.2.1.1 Used to Deliver Wide Range of Medications
Table 18 Single-Layer Drug-In-Adhesive Transdermal Patches Market, by Country, 2021-2029 (USD Million)
6.2.2 Multi-Layer Drug-In-Adhesive Patches
6.2.2.1 Enhanced Drug Release and Reduced Side Effects to Drive Adoption
Table 19 Multi-Layer Drug-In-Adhesive Transdermal Patches Market, by Country, 2021-2029 (USD Million)
6.3 Matrix Patches
6.3.1 Technological Advancements in New Matrix Materials to Support Market Growth
Table 20 Matrix Transdermal Patches Market, by Country, 2021-2029 (USD Million)
6.4 Reservoir Membrane Patches
6.4.1 Offer Great Control Over Drug Delivery Rates
Table 21 Reservoir Membrane Transdermal Patches Market, by Country, 2021-2029 (USD Million)
6.5 Microneedle Patches
6.5.1 Ability to Deliver Active Pharmaceutical Ingredients to Boost Adoption
Table 22 Microneedle Transdermal Patches Market, by Country, 2021-2029 (USD Million)
6.6 Iontophoresis Patches
6.6.1 Used to Deliver Medicines with Low Molecular Weight
Table 23 Iontophoresis Transdermal Patches Market, by Country, 2021-2029 (USD Million)
6.7 Vapor Patches
6.7.1 Release Essential Oils for Up to 6 Hours
Table 24 Vapor Transdermal Patches Market, by Country, 2021-2029 (USD Million)
7 Transdermal Patches Market, by Adhesive Type
7.1 Introduction
Table 25 Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
7.2 Acrylic Adhesives
7.2.1 High Durability to Boost Demand
Table 26 Transdermal Patches Market for Acrylic Adhesives, by Country, 2021-2029 (USD Million)
7.3 Silicone Adhesives
7.3.1 Low Peel Adhesion Property Makes IT Ideal for Medical Applications
Table 27 Transdermal Patches Market for Silicone Adhesives, by Country, 2021-2029 (USD Million)
7.4 Hydrogel Adhesives
7.4.1 Increasing Demand for Transdermal Drug Delivery Systems to Drive Market
Table 28 Transdermal Patches Market for Hydrogel Adhesives, by Country, 2021-2029 (USD Million)
7.5 Other Adhesives
Table 29 Transdermal Patches Market for Other Adhesives, by Country, 2021-2029 (USD Million)
8 Transdermal Patches Market, by Application
8.1 Introduction
Table 30 Transdermal Patches Market, by Application, 2021-2029 (USD Million)
8.2 Pain Management
8.2.1 High Burden of Chronic Pain Worldwide to Drive Market
Table 31 Transdermal Patches Available for Pain Management
Table 32 Transdermal Patches Market for Pain Management, by Country, 2021-2029 (USD Million)
8.3 Smoking Cessation
8.3.1 Controlled Drug Delivery and Reduced Side Effects to Support Market Growth
Table 33 Transdermal Patches Available for Smoking Cessation
Table 34 Transdermal Patches Market for Smoking Cessation, by Country, 2021-2029 (USD Million)
8.4 Hormone Replacement Therapy
Table 35 Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 36 Transdermal Patches Market for Hormone Replacement Therapy, by Country, 2021-2029 (USD Million)
8.4.1 Transdermal Testosterone Therapy
8.4.1.1 Increased Bone Density, Better Muscle Development, and Reduced Risk Factors to Support Market Growth
Table 37 Transdermal Patches Available for Transdermal Testosterone Therapy
Table 38 Transdermal Patches Market for Transdermal Testosterone Therapy, by Country, 2021-2029 (USD Million)
8.4.2 Transdermal Estrogen Therapy
8.4.2.1 Growing Use of Transdermal Contraceptive Patches to Drive Market
Table 39 Transdermal Patches Available for Transdermal Estrogen Therapy
Table 40 Transdermal Patches Market for Transdermal Estrogen Therapy, by Country, 2021-2029 (USD Million)
8.5 Central Nervous System Disorders
8.5.1 Ease of Use, Simple Treatment Regimen, and Continuous Delivery of Drugs to Drive Adoption
Table 41 Transdermal Patches Available for Central Nervous System Disorders
Table 42 Transdermal Patches Market for Central Nervous System Disorders, by Country, 2021-2029 (USD Million)
8.6 Cardiovascular Diseases
8.6.1 Availability of Alternative and Advanced Drug Delivery Options to Limit Market Growth
Table 43 Transdermal Patches Available for Cardiovascular Diseases
Table 44 Transdermal Patches Market for Cardiovascular Diseases, by Country, 2021-2029 (USD Million)
8.7 Other Applications
Table 45 Transdermal Patches Available for Other Applications
Table 46 Transdermal Patches Market for Other Applications, by Country, 2021-2029 (USD Million)
9 Transdermal Patches Market, by Distribution Channel
9.1 Introduction
Table 47 Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
9.2 Hospital Pharmacies
9.2.1 Largest Distribution Channel for Transdermal Patches
Table 48 Transdermal Patches Market for Hospital Pharmacies, by Country, 2021-2029 (USD Million)
9.3 Retail Pharmacies
9.3.1 Improving Healthcare Infrastructure to Drive Market
Table 49 Transdermal Patches Market for Retail Pharmacies, by Country, 2021-2029 (USD Million)
9.4 Online Pharmacies
9.4.1 Fastest-Growing Segment due to Easy Accessibility to Medications
Table 50 Transdermal Patches Market for Online Pharmacies, by Country, 2021-2029 (USD Million)
10 Transdermal Patches Market, by End-user
10.1 Introduction
Table 51 Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
10.2 Home Care Settings
10.2.1 Rapid Growth in Geriatric Population to Support Market Growth
Table 52 Transdermal Patches Market for Home Care Settings, by Country, 2021-2029 (USD Million)
10.3 Hospitals & Clinics
10.3.1 Increasing Prevalence of Chronic Diseases to Drive Market
Table 53 Transdermal Patches Market for Hospitals & Clinics, by Country, 2021-2029 (USD Million)
11 Transdermal Patches Market, by Region
11.1 Introduction
Table 54 Transdermal Patches Market, by Region, 2021-2029 (USD Million)
11.2 North America
11.2.1 Impact of Recession on North American Transdermal Patches Market
Figure 36 North America: Transdermal Patches Market Snapshot
Table 55 North America: Transdermal Patches Market, by Country, 2021-2029 (USD Million)
Table 56 North America: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 57 North America: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 58 North America: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 59 North America: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 60 North America: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 61 North America: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 62 North America: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.2.2 US
11.2.2.1 Largest Market for Transdermal Patches
Table 63 US: Macroeconomic Indicators
Table 64 US: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 65 US: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 66 US: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 67 US: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 68 US: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 69 US: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 70 US: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.2.3 Canada
11.2.3.1 Rising Funding for Transdermal Drug Delivery Research to Drive Market
Table 71 Canada: Macroeconomic Indicators
Table 72 Canada: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 73 Canada: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 74 Canada: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 75 Canada: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 76 Canada: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 77 Canada: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 78 Canada: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.3 Europe
11.3.1 Impact of Recession on European Transdermal Patches Market
Table 79 Europe: Transdermal Patches Market, by Country, 2021-2029 (USD Million)
Table 80 Europe: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 81 Europe: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 82 Europe: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 83 Europe: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 84 Europe: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 85 Europe: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 86 Europe: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.3.2 Germany
11.3.2.1 Favorable Government Policies to Aid Market Growth
Table 87 Germany: Macroeconomic Indicators
Table 88 Germany: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 89 Germany: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 90 Germany: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 91 Germany: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 92 Germany: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 93 Germany: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 94 Germany: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.3.3 UK
11.3.3.1 Increasing Funding for R&D of Innovative Transdermal Technologies to Drive Market
Table 95 UK: Macroeconomic Indicators
Table 96 UK: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 97 UK: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 98 UK: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 99 UK: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 100 UK: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 101 UK: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 102 UK: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.3.4 France
11.3.4.1 Development of Transdermal Drug Delivery Systems by Local Players to Support Market Growth
Table 103 France: Macroeconomic Indicators
Table 104 France: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 105 France: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 106 France: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 107 France: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 108 France: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 109 France: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 110 France: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.3.5 Italy
11.3.5.1 High Burden of Lung Cancer to Propel Market
Table 111 Italy: Macroeconomic Indicators
Table 112 Italy: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 113 Italy: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 114 Italy: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 115 Italy: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 116 Italy: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 117 Italy: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 118 Italy: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.3.6 Spain
11.3.6.1 Growing Demand for Self-Care and Personalized Medicine to Drive Market
Table 119 Spain: Macroeconomic Indicators
Table 120 Spain: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 121 Spain: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 122 Spain: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 123 Spain: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 124 Spain: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 125 Spain: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 126 Spain: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.3.7 Rest of Europe
Table 127 Rest of Europe: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 128 Rest of Europe: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 129 Rest of Europe: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 130 Rest of Europe: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 131 Rest of Europe: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 132 Rest of Europe: Transdermal Patches Market, by Distribution Channel 2021-2029 (USD Million)
Table 133 Rest of Europe: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.4 Asia-Pacific
11.4.1 Impact of Recession on Asia-Pacific Transdermal Patches Market
Figure 37 Asia-Pacific: Transdermal Patches Market Snapshot
Table 134 Asia-Pacific: Transdermal Patches Market, by Country, 2021-2029 (USD Million)
Table 135 Asia-Pacific: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 136 Asia-Pacific: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 137 Asia-Pacific: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 138 Asia-Pacific: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 139 Asia-Pacific: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 140 Asia-Pacific: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 141 Asia-Pacific: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.4.2 China
11.4.2.1 Large Diabetic Population to Drive Market
Table 142 China: Macroeconomic Indicators
Table 143 China: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 144 China: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 145 China: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 146 China: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 147 China: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 148 China: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 149 China: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.4.3 Japan
11.4.3.1 Increasing Number of Product Approvals and Growing Focus of Local Players on R&D of Transdermal Systems to Support Market Growth
Table 150 Japan: Macroeconomic Indicators
Table 151 Japan: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 152 Japan: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 153 Japan: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 154 Japan: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 155 Japan: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 156 Japan: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 157 Japan: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.4.4 India
11.4.4.1 Increasing Focus on Noninvasive Methods of Drug Delivery to Drive Market
Table 158 India: Macroeconomic Indicators
Table 159 India: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 160 India: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 161 India: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 162 India: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 163 India: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 164 India: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 165 India: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.4.5 South Korea
11.4.5.1 Rising Healthcare Spending and Increasing Government Initiatives to Propel Market
Table 166 South Korea: Macroeconomic Indicators
Table 167 South Korea: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 168 South Korea: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 169 South Korea: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 170 South Korea: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 171 South Korea: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 172 South Korea: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 173 South Korea: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.4.6 Australia
11.4.6.1 Increasing Number of Smokers to Drive Market
Table 174 Australia: Macroeconomic Indicators
Table 175 Australia: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 176 Australia: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 177 Australia: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 178 Australia: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 179 Australia: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 180 Australia: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 181 Australia: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.4.7 Rest of Asia-Pacific
Table 182 Rest of Asia-Pacific: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 183 Rest of Asia-Pacific: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 184 Rest of Asia-Pacific: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 185 Rest of Asia-Pacific: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 186 Rest of Asia-Pacific: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 187 Rest of Asia-Pacific: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 188 Rest of Asia-Pacific: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.5 Latin America
11.5.1 Impact of Recession on Transdermal Patches Market in Latin America
Table 189 Latin America: Transdermal Patches Market, by Country, 2021-2029 (USD Million)
Table 190 Latin America: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 191 Latin America: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 192 Latin America: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 193 Latin America: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 194 Latin America: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 195 Latin America: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 196 Latin America: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.5.2 Brazil
11.5.2.1 High Prevalence of Diabetes to Propel Market
Table 197 Brazil: Key Macroindicators
Table 198 Brazil: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 199 Brazil: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 200 Brazil: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 201 Brazil: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 202 Brazil: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 203 Brazil: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 204 Brazil: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.5.3 Mexico
11.5.3.1 Government Investments to Drive Transdermal Drug Delivery Production
Table 205 Mexico: Key Macroindicators
Table 206 Mexico: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 207 Mexico: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 208 Mexico: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 209 Mexico: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 210 Mexico: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 211 Mexico: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 212 Mexico: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.5.4 Rest of Latin America
Table 213 Rest of Latin America: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 214 Rest of Latin America: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 215 Rest of Latin America: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 216 Rest of Latin America: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 217 Rest of Latin America: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 218 Rest of Latin America: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 219 Rest of Latin America: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)
11.6 Middle East & Africa
11.6.1 Government Support to Boost Local Production to Offer Growth Opportunities for Transdermal Patch Manufacturers
11.6.2 Impact of Recession on Transdermal Patches Market in Middle East and Africa
Table 220 Middle East & Africa: Transdermal Patches Market, by Patch Type, 2021-2029 (USD Million)
Table 221 Middle East & Africa: Drug-In-Adhesive Transdermal Patches Market, by Type, 2021-2029 (USD Million)
Table 222 Middle East & Africa: Transdermal Patches Market, by Adhesive Type, 2021-2029 (USD Million)
Table 223 Middle East & Africa: Transdermal Patches Market, by Application, 2021-2029 (USD Million)
Table 224 Middle East & Africa: Transdermal Patches Market for Hormone Replacement Therapy, by Type, 2021-2029 (USD Million)
Table 225 Middle East & Africa: Transdermal Patches Market, by Distribution Channel, 2021-2029 (USD Million)
Table 226 Middle East & Africa: Transdermal Patches Market, by End-user, 2021-2029 (USD Million)

12 Competitive Landscape
12.1 Introduction
Table 227 Key Developments in Transdermal Patches Market (January 2020-October 2023)
12.2 Revenue Analysis of Key Market Players
Figure 38 Revenue Analysis of Key Players in Transdermal Patches Market
12.3 Market Share Analysis
Figure 39 Transdermal Patches Market Share, by Key Player, 2022
12.4 Company Footprint
12.4.1 Footprint of Companies in Transdermal Patches Market
12.4.2 Patch Type Footprint
12.4.3 Adhesive Type Footprint
12.4.4 Application Footprint
12.4.5 Distribution Channel Footprint
12.4.6 End-user Footprint
12.4.7 Regional Footprint
12.5 Transdermal Patches Market: R&D Expenditure
Figure 40 R&D Expenditure of Key Players in Transdermal Patches Market (2021 vs. 2022)
12.6 Company Evaluation Matrix
12.6.1 Stars
12.6.2 Emerging Leaders
12.6.3 Pervasive Players
12.6.4 Participants
Figure 41 Transdermal Patches Market: Company Evaluation Matrix, 2022
12.7 SME/Startup Evaluation Matrix
12.7.1 Progressive Companies
12.7.2 Starting Blocks
12.7.3 Responsive Companies
12.7.4 Dynamic Companies
Figure 42 Transdermal Patches Market: SME/Startup Evaluation Matrix
12.7.5 Competitive Benchmarking
Table 228 Transdermal Patches Market: Detailed List of Key Startup/SMEs
12.8 Competitive Situation and Trends
12.8.1 Product Launches
Table 229 Transdermal Patches Market: Product Launches, January 2020-October 2023
12.8.2 Deals
Table 230 Transdermal Patches Market: Deals, January 2020-October 2023
12.8.3 Other Developments
Table 231 Transdermal Patches Market: Other Developments, January 2020-October 2023
13 Company Profiles
(Business Overview, Products Offered, Recent Developments & Analyst's View)*
13.1 Key Players
13.1.1 Hisamitsu Pharmaceutical Co. Inc.
Table 232 Hisamitsu Pharmaceutical Co. Inc.: Business Overview
Figure 43 Hisamitsu Pharmaceutical Co. Inc.: Company Snapshot (2022)
13.1.2 Viatris Inc.
Table 233 Viatris Inc.: Business Overview
Figure 44 Viatris Inc.: Company Snapshot (2022)
13.1.3 Novartis AG
Table 234 Novartis AG: Business Overview
Figure 45 Novartis AG: Company Snapshot (2022)
13.1.4 Boehringer Ingelheim International GmbH
Table 235 Boehringer Ingelheim International GmbH: Business Overview
Figure 46 Boehringer Ingelheim International GmbH: Company Snapshot (2022)
13.1.5 Johnson & Johnson
Table 236 Johnson & Johnson: Business Overview
Figure 47 Johnson & Johnson: Company Snapshot (2022)
13.1.6 UCB SA
Table 237 UCB SA: Business Overview
Figure 48 UCB SA: Company Snapshot (2022)
13.1.7 Endo International PLC
Table 238 Endo International PLC: Business Overview
Figure 49 Endo International PLC: Company Snapshot (2022)
13.1.8 Luye Pharma Group
Table 239 Luye Pharma Group: Business Overview
Figure 50 Luye Pharma Group: Company Snapshot (2022)
13.1.9 Abbvie Inc.
Table 240 Abbvie Inc.: Business Overview
Figure 51 Abbvie Inc.: Company Snapshot (2022)
13.1.10 Nitto Denko Corporation
Table 241 Nitto Denko Corporation: Business Overview
Figure 52 Nitto Denko Corporation: Company Snapshot (2022)
13.1.11 Cipla Inc.
Table 242 Cipla Inc.: Business Overview
Figure 53 Cipla Inc.: Company Snapshot (2022)
13.1.12 Teva Pharmaceutical Industries Ltd.
Table 243 Teva Pharmaceutical Industries Ltd.: Business Overview
Figure 54 Teva Pharmaceutical Industries Ltd.: Company Snapshot (2022)
13.1.13 Agile Therapeutics
Table 244 Agile Therapeutics: Business Overview
Figure 55 Agile Therapeutics: Company Snapshot (2022)
13.1.14 Bayer AG
Table 245 Bayer AG: Business Overview
Figure 56 Bayer AG: Company Snapshot (2022)
13.1.15 Amneal Pharmaceuticals LLC
Table 246 Amneal Pharmaceuticals LLC: Business Overview
Figure 57 Amneal Pharmaceuticals LLC: Company Snapshot (2022)
13.1.16 Hikma Pharmaceuticals PLC
Table 247 Hikma Pharmaceuticals PLC: Business Overview
Figure 58 Hikma Pharmaceuticals PLC: Company Snapshot (2022)
*Details on Business Overview, Products Offered, Recent Developments & Analyst's View Might Not be Captured in Case of Unlisted Companies
13.2 Other Players
13.2.1 Alvogen Group Inc.
Table 248 Alvogen Group Inc.: Company Overview
13.2.2 Sparsha Pharma International Pvt. Ltd.
Table 249 Sparsha Pharma International Pvt. Ltd.: Company Overview
13.2.3 Iontopatch
Table 250 Iontopatch: Company Overview
13.2.4 Medherant Limited
Table 251 Medherant Limited: Company Overview
13.2.5 Adhexpharma
Table 252 Adhexpharma: Company Overview
13.2.6 Evernow
Table 253 Evernow: Company Overview
13.2.7 Lead Chemical Co. Ltd.
Table 254 Lead Chemical Co. Ltd.: Company Overview
13.2.8 Purdue Pharma L.P.
Table 255 Purdue Pharma L.P.: Company Overview
13.2.9 Mundipharma International
Table 256 Mundipharma International: Company Overview
13.3 Companies Providing Adhesives for Transdermal Patches
13.3.1 Wacker Chemie AG
13.3.1.1 Business Overview
Table 257 Wacker Chemie AG: Business Overview
Figure 59 Wacker Chemie AG: Company Snapshot (2022)
13.3.1.2 Products Offered
13.3.2 Elkem ASA
13.3.2.1 Business Overview
Table 258 Elkem ASA: Business Overview
Figure 60 Elkem ASA: Company Snapshot (2022)
13.3.2.2 Products Offered
13.3.3 DuPont de Nemours, Inc.
13.3.3.1 Business Overview
Table 259 DuPont de Nemours, Inc.: Business Overview
Figure 61 DuPont de Nemours, Inc.: Company Snapshot (2022)
13.3.3.2 Products Offered
13.3.4 Katecho, LLC
Table 260 Katecho, LLC: Company Overview
13.3.5 Polymer Science, Inc.
Table 261 Polymer Science, Inc.: Company Overview
14 Appendix
14.1 Discussion Guide
14.2 KnowledgeStore: The Subscription Portal
14.3 Customization Options

Companies Mentioned

  • Abbvie Inc.
  • Adhexpharma
  • Agile Therapeutics
  • Alvogen Group Inc.
  • Amneal Pharmaceuticals LLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Inc.
  • DuPont de Nemours, Inc.
  • Elkem ASA
  • Endo International PLC
  • Evernow
  • Hikma Pharmaceuticals PLC
  • Hisamitsu Pharmaceutical Co. Inc.
  • Iontopatch
  • Johnson & Johnson
  • Katecho, LLC
  • Lead Chemical Co. Ltd.
  • Luye Pharma Group
  • Medherant Limited
  • Mundipharma International
  • Nitto Denko Corporation
  • Novartis AG
  • Polymer Science, Inc.
  • Purdue Pharma L.P.
  • Sparsha Pharma International Pvt. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • UCB SA
  • Viatris Inc.
  • Wacker Chemie AG

Table Information